Page last updated: 2024-09-03

panaxydol and Hepatocellular Carcinoma

panaxydol has been researched along with Hepatocellular Carcinoma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Guo, LC; Song, L; Sun, YN; Wang, ZJ; Yin, M1

Other Studies

1 other study(ies) available for panaxydol and Hepatocellular Carcinoma

ArticleYear
Induction of differentiation by panaxydol in human hepatocarcinoma SMMC-7721 cells via cAMP and MAP kinase dependent mechanism.
    Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2011, Volume: 131, Issue:6

    Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Differentiation; Cell Proliferation; Cell Survival; Cyclic AMP; Depression, Chemical; Diynes; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Extracellular Signal-Regulated MAP Kinases; Fatty Alcohols; Humans; Liver Neoplasms; Microscopy, Electron, Transmission; Signal Transduction; Tumor Cells, Cultured

2011